In the Spotlight

Celebrating CCR Careers: William G. Stetler-Stevenson, M.D., Ph.D.

For over three decades, William G. Stetler-Stevenson, M.D., Ph.D., has been a leader in the field of tissue inhibitors of metalloproteinases (TIMP) biology and extracellular matrix regulation of cancer.

Celebrating CCR Careers: Allan M. Weissman, M.D.

Allan M. Weissman, M.D., who explored the essential underpinning of ubiquitin in cancer, announces his retirement from the NCI.

Celebrating CCR Careers: Kathleen Kelly, Ph.D.

Kathleen Kelly, Ph.D., who pioneered new frameworks for modeling and exploring how prostate cancer cells respond to anti-cancer drugs, announces her retirement from the NCI.

Celebrating CCR Careers: Kenneth H. Kraemer, M.D.

For more than fifty years, Kenneth H. Kraemer, M.D., has investigated the molecular underpinnings and clinical manifestations of xeroderma pigmentosum, a rare disease that makes children highly vulnerable to skin damage and cancers from ultraviolet radiation, at the NCI.

Listening to communities to improve cancer care: a conversation with Dr. Brenda Adjei

Brenda Adjei, Ed.D., M.P.A., is the new Associate Director of the Office of Healthcare Delivery and Equity Research. In this Q&A, Dr. Adjei discusses her career and the importance of including underserved populations at every level of clinical trials to improve health outcomes.

CCR Hosts “Frontiers in Basic Immunology” Symposium

CCR hosted a two-day international symposium, titled “Frontiers in Basic Immunology,” sponsored by the NCI Center of Excellence in Immunology (CEI). The program included a lineup of presentations from NCI and worldwide academic university speakers and a lively poster session.

CCR Hosts Communications Course for Healthcare Providers in Oncology

Dedicated transdisciplinary teams of healthcare providers from the CCR’s Clinical Care Programs gathered to learn communication skills centered on essential topics of patient care.

In Memoriam: W. Michael Kuehl, M.D.

The CCR community is deeply saddened by the recent passing of W. Michael Kuehl, M.D., former Senior Investigator in the Genetics Branch.

New Milestones publication now available

Every year, CCR makes remarkable contributions to the understanding, detection, treatment and prevention of cancer. This issue of our annual publication, Milestones, features 10 of our top scientific advances from the past year. These discoveries include advances in precision medicine — such as the identification of biomarkers that predict a patient’s response to immunotherapy or lead to health disparities — as well as research on a widely applicable cancer vaccine that could be employed in low-resource settings. Promising research on T cells provides insights into their resilience, behavior and tumor-reactivity with an eye toward developing better immunotherapies, and technological advances provide close-ups of key components of tumor growth and metastasis.

Celebrating Hispanic Heritage Month: A Conversation with Cecilia Monge, M.D., M.P.H., F.A.C.P.

Cecilia Monge, M.D., M.P.H., F.A.C.P., is an Assistant Research Physician in the Thoracic and GI Malignancies Branch. She is from Costa Rica where she completed medical school and worked for ten years. For this Hispanic Heritage Month Q&A, she tells us about her interests in health disparities research, her experience working in a developing country and what makes a good mentor.

Breadcrumb